| 000 | 01753 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518031713.0 | ||
| 264 | 0 | _c20190603 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1471-6771 | ||
| 024 | 7 |
_a10.1016/j.bja.2019.02.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTanaka, K A | |
| 245 | 0 | 0 |
_aElevated fibrinogen, von Willebrand factor, and Factor VIII confer resistance to dilutional coagulopathy and activated protein C in normal pregnant women. _h[electronic resource] |
| 260 |
_bBritish journal of anaesthesia _cJun 2019 |
||
| 300 |
_a751-759 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBlood Coagulation Disorders _xblood |
| 650 | 0 | 4 |
_aBlood Coagulation Factors _xanalysis |
| 650 | 0 | 4 |
_aBlood Specimen Collection _xmethods |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 |
_aFactor VIII _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinogen _xanalysis |
| 650 | 0 | 4 |
_aHemodilution _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy Complications, Hematologic _xblood |
| 650 | 0 | 4 |
_aProtein C _xanalysis |
| 650 | 0 | 4 |
_aThrombelastography _xmethods |
| 650 | 0 | 4 |
_aThrombin _xbiosynthesis |
| 650 | 0 | 4 | _aYoung Adult |
| 650 | 0 | 4 |
_avon Willebrand Factor _xanalysis |
| 700 | 1 | _aBharadwaj, S | |
| 700 | 1 | _aHasan, S | |
| 700 | 1 | _aJudd, M | |
| 700 | 1 | _aAbuelkasem, E | |
| 700 | 1 | _aHenderson, R A | |
| 700 | 1 | _aChow, J H | |
| 700 | 1 | _aWilliams, B | |
| 700 | 1 | _aMazzeffi, M A | |
| 700 | 1 | _aCrimmins, S D | |
| 700 | 1 | _aMalinow, A M | |
| 773 | 0 |
_tBritish journal of anaesthesia _gvol. 122 _gno. 6 _gp. 751-759 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bja.2019.02.012 _zAvailable from publisher's website |
| 999 |
_c29521162 _d29521162 |
||